- Home
- RPID vs PROK Comparison
RPID vs PROK Comparison
Compare RPID & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- PROK
- Stock Information
- Founded
- RPID 2006
- PROK 2015
- Country
- RPID United States
- PROK United States
- Employees
- RPID N/A
- PROK N/A
- Industry
- RPID Medical Specialities
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RPID Health Care
- PROK Health Care
- Exchange
- RPID Nasdaq
- PROK Nasdaq
- Market Cap
- RPID 155.6M
- PROK 129.5M
- IPO Year
- RPID 2021
- PROK N/A
- Fundamental
- Price
- RPID $3.32
- PROK $0.71
- Analyst Decision
- RPID Buy
- PROK Buy
- Analyst Count
- RPID 1
- PROK 3
- Target Price
- RPID $8.00
- PROK $4.50
- AVG Volume (30 Days)
- RPID 94.0K
- PROK 667.1K
- Earning Date
- RPID 08-01-2025
- PROK 08-08-2025
- Dividend Yield
- RPID N/A
- PROK N/A
- EPS Growth
- RPID N/A
- PROK N/A
- EPS
- RPID N/A
- PROK N/A
- Revenue
- RPID $29,645,000.00
- PROK $306,000.00
- Revenue This Year
- RPID $18.54
- PROK $54.34
- Revenue Next Year
- RPID $20.55
- PROK N/A
- P/E Ratio
- RPID N/A
- PROK N/A
- Revenue Growth
- RPID 28.36
- PROK N/A
- 52 Week Low
- RPID $0.58
- PROK $0.46
- 52 Week High
- RPID $4.04
- PROK $2.75
- Technical
- Relative Strength Index (RSI)
- RPID 50.47
- PROK 44.48
- Support Level
- RPID $3.00
- PROK $0.69
- Resistance Level
- RPID $3.73
- PROK $1.02
- Average True Range (ATR)
- RPID 0.25
- PROK 0.11
- MACD
- RPID -0.07
- PROK -0.01
- Stochastic Oscillator
- RPID 40.51
- PROK 13.58
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.